# CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation

> **NCT00422435** · PHASE3 · COMPLETED · sponsor: **Conor Medsystems** · enrollment: 107 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** CoStar™ Paclitaxel-Eluting Coronary Stent with SRX catheter

## Key facts

- **NCT ID:** NCT00422435
- **Lead sponsor:** Conor Medsystems
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-05
- **Final completion:** 2008-05
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2008-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422435, "CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00422435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*